Journals / JAREM / 2017 / Cilt: 7 - Sayı: 1

Assessment of Pulmonary Hypertension Exposure to Biomass Smoke in Female Patients

Biomass Maruziyeti Olan Kadın Olgularda Pulmoner Arter Basıncının Değerlendirilmesi

Journal
JAREM
Pages
16–20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results suggest that biomass exposure is related to pulmonary hypertension even without respiratory symptoms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Pulmonary hypertension is a common complication among patients with advanced stage chronic obstructive pulmonary disease (COPD).
📊
Key Findings & Data:Fifty-two of these patients who were diagnosed with COPD, according to GOLD criteria, were included in the study as the study group and 12 patients with no respiratory problem and normal respiratory function test were included as the control group.Systolic pulmonary arterial pressure (sPAB) of >35 mmHg was accepted as the presence of suspected pulmonary hypertension.
💡
Conclusion & Impact:These results suggest that biomass exposure is related to pulmonary hypertension even without respiratory symptoms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Pulmonary hypertension is a common complication among patients with advanced stage chronic obstructive pulmonary disease (COPD). In communities using animal biomass fuels, biomass exposure causes COPD in females as much as it does in males, or even more. The aim of our study was to investigate the existence of pulmonary hypertension in biomass-exposed females. Methods: Ninety non-smoking female patients who were previously exposed to biomass and underwent echocardiography examinations were retrospectively analyzed. Fifty-two of these patients who were diagnosed with COPD, according to GOLD criteria, were included in the study as the study group and 12 patients with no respiratory problem and normal respiratory function test were included as the control group.Systolic pulmonary arterial pressure (sPAB) of >35 mmHg was accepted as the presence of suspected pulmonary hypertension. Results: High sPAB was detected in the study group, according to reference value (38.3±10.7). In the control group, sPAB was found to be 32.5±7.6 mmHg. However, no statistical significance in sPAB was found between the two groups. Conclusion: In our study, the absolute value of sPAB was determined to be higher in the biomass-exposed COPD patients than in the normal controls. However, no statistical significance in echocardiography measurements was observed between the control and COPD patients. These results suggest that biomass exposure is related to pulmonary hypertension even without respiratory symptoms. As a result, cohort studies on the relationship between biomass exposure and pulmonary hypertension will help increase awareness of a very important public health problem and help decrease biomass exposure

Özet

Amaç: Pulmoner hipertansiyon ileri evre Kronik Obstrüktif Akciğer Hastalığı (KOAH) olan olgularda sık görülen bir komplikasyondur. Hayvansal biyokütle yakıtı (tezek) kullanan toplumlarda biomass maruziyeti, kadınlar da erkekler kadar, hatta daha yüksek oranda KOAH görülmesine yol açmaktadır. Çalışmamızda sigara içmeyen ve biomass maruziyeti olan kadın olgularda, pulmoner hipertansiyon varlığını araştırmayı amaçladık. Yöntemler: Sigara içmeyen, biomass maruziyeti olan ve Ekokardiyografik inceleme yapılmış 90 kadın olgu retrospektif olarak değerlendirildi. Bu olgulardan GOLD kriterlerine göre tanı konulan 52 KOAH'lı olgu çalışmaya alındı. Biomass maruziyeti olan, solunumsal yakınması olmayan ve solunum fonksiyon testleri normal sınırlarda 12 olgu kontrol grubu olarak seçildi. Sistolik pulmoner arter basıncının (sPAB)>35 mmHg olması pulmoner hipertansiyon varlığı kuşkusu olarak kabul edildi. Bulgular: KOAH grubunda s(PAB) ekokardiyografik ölçümde referans değerlere göre yüksek saptandı (38,3±10,7). Kontrol grubunda ise s PAB 32,5±7,6 mmHg arasında bulundu. Ancak s(PAB) açısından iki grup arasında istatistiki olarak anlamlı bir fark bulunamadı.Sonuç: Çalışmamızda; s(PAB)'nin mutlak değeri, biomass maruziyeti olan KOAH'lı olgularda daha yüksek saptandı. Ancak, KOAH'lı ve kontrol olguların s(PAB) ekokardiyografik ölçüm değerleri arasında istatistiksel anlamlı fark saptanmadı. Bu bulgular biomass maruziyetinin solunum semptomları olmaksızın da pulmoner hipertansiyonla ilişkili olabileceğini göstermektedir. Sonuç olarak biomass maruziyeti ve pulmoner hipertansiyon ilişkisinin yeni cohort çalışmalarla araştırılması önemli bir halk sağlığı problemiyle ilgili farkındalığı artırarak gerekli önlemlerin alınmasına katkı sağlayabilir

🔖

Cite This Article

KANMAZ, Z. D., ÖZÜLKÜ, E., YENTÜRK, E., ARAS, G., TUNCAY, E., GÜLSÜM, A. (2017). Assessment of Pulmonary Hypertension Exposure to Biomass Smoke in Female Patients. JAREM, Cilt: 7 - Sayı: 1, 16–20. https://ajindex.com/articles/200997

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Sood A. Indoor fuel exposure and the lung in both developing and developed countries. An update Clin Chest Med 2012; 33: 649-65
  2. Rehfuess E, Mehta S, Pruss-Ustun A. Assessing household solid fuel use: multiple implications for the Millennium Development Goals. Environ Health Perspect 2006; 114: 373-8
  3. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, DiezRoux AV, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation 2010; 121: 2331-78
  4. Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA. Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci 2012; 9: 406-12
  5. Global initiative for chronic obstructive lung disease, global strategy for the diagnosis, management and prevention of chronic obstructive lung disease, updated 2015 Available at: www.goldcopd.org. [Retrieved Dec 2015;21]
  6. Papathanasiou A, Nakos G. Why there is a need to discuss pulmonary hypertension other than pulmonary arterial hypertension? World J Crit Care Med 2015; 4: 274-7
  7. Quanjer H, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Standardised lung function testing; lung volumes and forced ventilatory flows. Eur Respir J 1993; 6(Suppl 16): 5-40
  8. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: 55-66
  9. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Systematic review and meta-analysis.Global Health Epidemiology Reference Group (GHERG). J Glob Health 2015; 5: 020415
  10. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442
  11. Yasin A, Özlü T. Türkiye’de KOAH epidemiyolojisi. Güncel Göğüs Hastalıkları Serisi 2013; 1: 7-12
  12. Torres Tajes JP, Macario CC. Chronic obstructive pulmonary disease in women. Arch Bronconeumol 2010; 46(Suppl 3): 23-7
  13. Martinez CH, Han MK. Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes. Med Clin North Am 2012; 96: 713-27
  14. Özbay B, Yener Z, Acar Ş, Kanter M. Histopathological changes in the lung of rat following long-term exposure to biomass smoke. Turkiye Klinikleri J Med Sci 2009; 29: 877-83
  15. Buturak A, Genç A, Ulus OS, Duygu E, Okmen AS, Uyarel H. Evaluation of the effects of chronic biomass fuel sm